Woori IO Leverages FDA's Non-Medical Wearable Clarification for Market Launch Woori IO has announced how FDA's recent clarification regarding non-medical wearables will help accelerate its commercialization of glucose monitoring technology.

Woori IO Leverages FDA's Non-Medical Wearable Clarification for Market Launch #USA #FDA #Bellevue #OSR_Holdings #Woori_IO

Woori IO Shareholders Approve Major Share Exchange with OSR Holdings The shareholders of Woori IO have approved a crucial share exchange with OSR Holdings, marking a new chapter in healthcare innovation and market expansion.

Woori IO Shareholders Approve Major Share Exchange with OSR Holdings #South_Korea #Jeonju #OSR_Holdings #Woori_IO #glucose_technology

OSR Holdings to Showcase Innovative Healthcare Strategies at Emerging Growth Conference 2025 OSR Holdings, Inc. will present its strategic initiatives at the Emerging Growth Conference on December 10, 2025, focusing on healthcare advancements.

OSR Holdings to Showcase Innovative Healthcare Strategies at Emerging Growth Conference 2025 #USA #Bellevue #Emerging_Growth #OSR_Holdings #Biomedical_Innovations

Dr. Andreas Niethammer Appointed CEO of Vaximm AG, Steering Immuno-Oncology Innovation Forward OSR Holdings has named Dr. Andreas Niethammer as CEO of Vaximm AG, advancing its immuno-oncology mission with innovative oral T-cell vaccines targeting cancer.

Dr. Andreas Niethammer Appointed CEO of Vaximm AG, Steering Immuno-Oncology Innovation Forward #United_States #Bellevue #Immuno-Oncology #OSR_Holdings #Vaximm_AG

OSR Holdings' Woori IO Noninvasive Glucose Monitor Shows Impressive Accuracy in Latest Study OSR Holdings reports significant findings from a pilot study on Woori IO's noninvasive glucose monitor, highlighting its accuracy and usability.

OSR Holdings' Woori IO Noninvasive Glucose Monitor Shows Impressive Accuracy in Latest Study #USA #Bellevue #OSR_Holdings #Woori_IO #Noninvasive_Glucose

OSR Holdings Announces Acquisition of Woori IO for Diabetes Innovation OSR Holdings, Inc. has signed a definitive agreement to acquire Woori IO, a leader in noninvasive glucose monitoring technology, promising advancements in diabetes care.

OSR Holdings Announces Acquisition of Woori IO for Diabetes Innovation #USA #Bellevue #Diabetes_Care #OSR_Holdings #Woori_IO

OSR Holdings Faces Nasdaq Compliance Challenge Amid Notable Trading Volatility OSR Holdings has received a notification from Nasdaq regarding a minimum bid price deficiency, sparking concerns over trading volatility and potential market manipulation.

OSR Holdings Faces Nasdaq Compliance Challenge Amid Notable Trading Volatility #USA #NASDAQ #Bellevue,_Washington #OSR_Holdings #trading_volatility

OSR Holdings to Host Investor Event: Insights on Strategic Growth and Innovations OSR Holdings, a leader in global healthcare, will host a virtual investor event on August 6, 2025, to discuss corporate strategies and innovations.

OSR Holdings to Host Investor Event: Insights on Strategic Growth and Innovations #United_States #Bellevue #OSR_Holdings #Biomedical_Innovations #Virtual_Investor_Event

OSR Holdings Shares Key Updates on Myriad of Equity Financing Activities OSR Holdings shares important insights into their equity financing instruments, emphasizing the investment in innovative healthcare initiatives to enhance value.

OSR Holdings Shares Key Updates on Myriad of Equity Financing Activities #USA #Bellevue #Equity_Financing #OSR_Holdings #biomedical_innovation

OSR Holdings' Strategic Move to Acquire Woori IO and Transform Glucose Monitoring OSR Holdings has announced a strategic agreement with Woori IO for a share exchange, marking a significant advancement in noninvasive glucose monitoring technology.

OSR Holdings' Strategic Move to Acquire Woori IO and Transform Glucose Monitoring #United_States #Bellevue #glucose_monitoring #OSR_Holdings #Woori_IO

OSR Holdings Aims for Groundbreaking Acquisition of Woori IO's Noninvasive Glucose Monitoring Tech OSR Holdings has signed a term sheet to acquire Woori IO, known for its innovative noninvasive glucose monitoring technology, marking a significant strategic move in healthcare.

OSR Holdings Aims for Groundbreaking Acquisition of Woori IO's Noninvasive Glucose Monitoring Tech #USA #Bellevue #glucose_monitoring #OSR_Holdings #Woori_IO

OSR Holdings Enhances Leadership with Dr. Andreas Niethammer as CMO for Vaximm AG Dr. Andreas Niethammer has been appointed as CMO of Vaximm AG, an OSR Holdings subsidiary, to lead oncology and immunotherapy advancements in clinical trials.

OSR Holdings Enhances Leadership with Dr. Andreas Niethammer as CMO for Vaximm AG #Switzerland #Basel #OSR_Holdings #Vaximm_AG #Dr._Niethammer

OSR Holdings Unveils Innovative Security Token Offering with BCM Europe AG Partnership OSR Holdings, in collaboration with BCM Europe AG, is set to launch a $50 million security token offering that integrates blockchain with healthcare innovation.

OSR Holdings Unveils Innovative Security Token Offering with BCM Europe AG Partnership #USA #Blockchain #Bellevue #OSR_Holdings #Tac_Token

OSR Holdings Introduces Strategic Roadmap for Tokenization with BCM Europe AG OSR Holdings unveils a strategic plan for a $50 million token offering under Regulation D, collaborating with BCM Europe AG to redefine healthcare investment.

OSR Holdings Introduces Strategic Roadmap for Tokenization with BCM Europe AG #United_States #Bellevue #OSR_Holdings #BCM_Europe_AG #Taekwondo_Access_Credit

OSR Holdings Partners with BCM Europe and Taekwondo Cooperative for Blockchain Innovation OSR Holdings has entered an MOU with BCM Europe and Taekwondo Cooperative to create the OSRH Token, enhancing crypto accessibility in wellness.

OSR Holdings Partners with BCM Europe and Taekwondo Cooperative for Blockchain Innovation #South_Korea #Seoul #OSR_Holdings #OSRH_Token #Taekwondo_Cooperative

Darnatein Set to Showcase Innovations at the International BMP Conference Focused on Regenerative Medicine Darnatein, a subsidiary of OSR Holdings Inc., will present breakthroughs in regenerative biologics at the BMP Conference, showcasing their innovative BMP chimeras.

Darnatein Set to Showcase Innovations at the International BMP Conference Focused on Regenerative Medicine #United_States #Philadelphia #OSR_Holdings #Darnatein #BMP_Conference

OSR Holdings Secures $80 Million for Accelerating Glioblastoma Therapies through Strategic Partnership OSR Holdings, Inc. announces an $80 million stock purchase agreement with White Lion GBM Innovation Fund to enhance glioblastoma treatments, driving healthcare innovation.

OSR Holdings Secures $80 Million for Accelerating Glioblastoma Therapies through Strategic Partnership #None #Glioblastoma #OSR_Holdings #White_Lion_Fund

OSR Holdings, Inc. and OSR Holdings Co., Ltd. Finalize Business Merger Announcement OSR Holdings, Inc. announces the successful completion of its merger with OSR Holdings Co., Ltd., effective February 2025, as it prepares for stock trading.

OSR Holdings, Inc. and OSR Holdings Co., Ltd. Finalize Business Merger Announcement #South_Korea #Seoul #Inc. #healthcare #OSR_Holdings #Bellevue_Life_Sciences

Bellevue Life Sciences Acquisition Corp. Transitions to OSR Holdings, Inc. Following Business Combination Approval Bellevue Life Sciences Acquisition Corp. has received approval for its business combination proposal and will rebrand as OSR Holdings, Inc., creating new opportunities in healthcare.

Bellevue Life Sciences Acquisition Corp. Transitions to OSR Holdings, Inc. Following Business Combination Approval #South_Korea #Seoul #healthcare #OSR_Holdings #BLAC